Pharma News

Sanofi, Cipla announce exclusive distribution partnership of CNS product

Sanofi India Limited and Cipla Limited have announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium®, a leading brand in the anti-epileptic medication category. 

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programs to expand access to these treatments for patients who need them.

Medlarge

Recent Posts

Health experts highlight informational gap in non-communicable diseases response

Recognizing the increasing burden of non-communicable diseases (NCDs) and the pivotal role of improving understanding…

17 hours ago

Finally Delhi to implement Ayushman Bharat Yojana, signs pact with Health Ministry

The BJP-led Delhi government on Saturday entered into an agreement with the Union health ministry…

2 days ago

In a first, ICMR to study zoonotic diseases that could spill over from birds to humans

In a one of its kind research, India is set to begin an inter-ministerial scientific…

3 days ago

World Homoeopathy Day 2025: Symposium to expand avenues of ‘Gentle Therapeutic System’

As an ode to Dr. Samuel Hahnemann, the founder of homoeopathy, on his birth-anniversary on…

4 days ago

RJD chief Lalu Yadav admitted at AIIMS

RJD president and former Bihar chief minister Lalu Prasad was on Wednesday taken to Delhi…

5 days ago

EVOLVE 2025 held to discuss advancements in extracellular vesicle (EV) research in AIIMS

The Indian Society for Extracellular Vesicles (InSEV) successfully hosted its inaugural conference, EVOLVE 2025, from…

5 days ago